Christopher David Ozeroff - S.V.P., General Counsel at Oruka Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
S.V.P., General Counsel
Stock Symbol
ORKA, ABIO on Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Christopher David Ozeroff since 10/5/2023

Holdings reported by Christopher David Ozeroff for Oruka Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 51K $127K $2.50 Dec 14, 2021 Direct
Stock Option (right to buy) 27.5K Dec 14, 2021 Direct Common Stock

Transactions reported by Christopher David Ozeroff for Oruka Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.